Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...

Mechanism of Angiogenesis

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...

The Retinoblastoma Gene

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Vitamin D supplementation during pregnancy: Position statement of the Groupe de Recherche et d'Information sur les Osteoporoses.

Joint bone spine·2026

Same author

Sevoflurane does not restore alveolar fluid clearance in a murine model of endotoxin-induced acute lung injury.

Scientific reports·2026

Same author

The value-based score in laboratory medicine: results of a European pilot study.

Clinical chemistry and laboratory medicine·2026

Same author

Capillary UCH-L1 protein blood measurement is affected by sample hemolysis.

Clinical chemistry and laboratory medicine·2026

Same author

Postmenopausal Osteoporosis, Endothelial Dysfunction, and Cardiovascular Risk.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2026

Same author

[Summary of the 34th National Conference of the National College of Hospital Biochemistry].

Annales de biologie clinique·2026

Search research articles

Related Experiment Videos

The changes in angiogenic gene expression in recurrent multiple chorioangiomas.

Denis Gallot¹, Geoffroy Marceau, Hélène Laurichesse-Delmas

¹CHU Clermont-Ferrand, Foetal Maternal Medicine Unit, Federation of Gynaecology and Obstetrics, Maternité Hôtel-Dieu, Clermont-Ferrand, France. dgallot@chu-clermontferrand.fr

Fetal Diagnosis and Therapy

|January 18, 2007

Summary

Recurrent multiple chorioangiomas disrupt placental angiogenesis, altering expression of key growth factors and cytokines. This complexity makes identifying a single causative gene challenging.

Related Experiment Videos

Area of Science:

Reproductive biology
Developmental biology
Molecular genetics

Background:

Recurrent multiple chorioangiomas are rare placental tumors.
Angiogenesis, the formation of new blood vessels, is crucial for placental development.
Dysregulation of angiogenic factors may contribute to chorioangioma development.

Observation:

Messenger ribonucleic acid (mRNA) expression analysis was performed on affected and normal placental tissues.
Complementary deoxyribonucleic acid (cDNA) array analysis compared mRNA levels of 96 angiogenesis-related genes.
One case of recurrent multiple chorioangiomas was studied.

Findings:

Eleven genes showed more than two-fold alteration in mRNA expression.
Genes such as angiopoietin 1, osteonectin, and neuropilin 1 were undetectable.
Vascular endothelial growth factor receptor 2 and EGF receptor expression were decreased, while angiopoietin 2 and osteopontin were increased.

Implications:

The study highlights the intricate disruption of placental angiogenesis in recurrent multiple chorioangiomas.
The complex molecular alterations suggest that a single gene cannot explain the pathology.
Further research is needed to understand the multifaceted mechanisms underlying chorioangiomas.